Home  »  Companies   »  T2 Biosystems Inc.’s (TTOO) Stock Behavior Isn...

T2 Biosystems Inc.’s (TTOO) Stock Behavior Isn’t As Predictable As You Thought

T2 Biosystems Inc. (NASDAQ:TTOO) concluded the trading at $0.26 on Thursday, September 14 with a fall of -4.98% from its closing price on previous day.

Taking a look at stock we notice that its last check on previous day was $0.28 with its price kept floating in the range of $0.2561 and $0.2788 on the day. Considering stock’s 52-week price range provides that TTOO hit a high price of $6.48 and saw its price falling to a low level of $0.05 during that period. Over a period of past 1-month, stock came subtracting -55.79% in its value.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


With its current market valuation of $98.66 million. Analysts are in estimates of -$0.04 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$0.24 for 2023 with estimates of that growing to -$0.09 in next year. These estimates are suggesting current year growth of 98.00% for EPS and 62.50% growth next year.

Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of $2.6 million. They suggested that in the process company could generate revenue of as low as $2.6 million which could climb up to $2.6 million to hit a high. The average estimate is representing a decrease of -55.90% in sales growth from that of posted by the company in the same quarter of last year. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of $10 million in 2023, which will be -55.20% less from revenue generated by the company last year.

In last 7 days, analysts came adjusting their opinions about stock’s EPS with no upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review TTOO stock’s current outlook then short term indicators are assigning it an average of Hold, while medium term indicators are categorizing the stock at an average of 50% Sell. Long term indicators are suggesting an average of 50% Sell for it.

According to ratings assigned by 2 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; 2 of them are recommending T2 Biosystems Inc. (TTOO) as a Hold, while 0 are in view that stock is a Buy. Recommendation by 0 analysts for the stock is an Underweight while number of those analysts who rated the stock as an Overweight is 0, whereas 0 of them are considering the stock as a Sell. When taken as whole, stock gets a rating of Overweight and that encourages the investors to exploit the opportunity and build their stake up in the company.

Digging deeper we become aware of the PEG ratio of the TTOO stock which is currently positioned at 0. It further provides that stock’s current price level is -30.37% away from its 20-day simple moving average and is -0.85% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 44.55 while volatility remained at 14.92% over the past week which changes to 23.25% when measuring it over the past month. Beta is valued at 0.28, while measure of average true range or ATR is currently at 0.07. In predicting price targets of as low as $0.12 and as high as $0.18, analysts are in agreement on assigning the stock over the next 12 months average price target of $0.15. Stock’s current price level is 53.85% above from estimated low price target while it is 30.77% below the estimated high; and even if the TTOO’s share succeeded to reach the median price of $0.15, then the outlook of 42.31% could come to the excitement of the investors.

Having a second look at T2 Biosystems Inc. (NASDAQ:TTOO) provides that stock’s average daily trading volume for 3 months was 108.92 million, while it jumped to 47.52 million when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 333.58 million.

The percentage of outstanding shares held by the insiders is 0.30% while it is 6.80% for the institutional holders. The figures also indicate that as of Aug 14, 2023, number of stock’s short shares was 26.87 million which implies a short ratio of 0.18. This shows up a 8.05% of Short Interest in company’s outstanding shares on the day. In August the standing of shares short improved as it was 1.91 million in the previous month. Subtraction of -81.60% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.